Incorporating patient-reported outcome measures (PROMs) into a clinical quality registry (CQR) for ovarian cancer: considerations and challenges
- Author(s)
- Lefkovits, YR; Heriot, N; Sporik, A; Perera, S; Friedlander, M; Dixon, C; Cohen, PA; Lee, YC; Hyde, S; Richardson, G; Webb, P; Rome, R; King, M; Zalcberg, J; Schofield, P;
- Details
- Publication Year 2024-07-08,Volume 24,Issue #1,Page 778
- Journal Title
- BMC Health Services Research
- Publication Type
- Review
- Abstract
- As medical treatment increasingly focuses on improving health-related quality of life, patient-reported outcome measures (PROMs) are an essential component of clinical research. The National Gynae-Oncology Registry (NGOR) is an Australian clinical quality registry. A suitable PROM was required for the NGOR ovarian cancer module to complement clinical outcomes and provide insights into outcomes important to patients. Our narrative review aimed to identify existing ovarian cancer-specific PROMs and ascertain which tool would be most appropriate for implementation into the NGOR ovarian cancer module.A literature review of Cochrane Library, Embase, MEDLINE and PubMed databases was performed to identify existing ovarian cancer-specific PROM tools. A steering committee was convened to (1) determine the purpose of, and criteria for our required PROM; and (2) to review the available tools against the criteria and recommend the most appropriate one for implementation within the NGOR.The literature review yielded five tools: MOST, EORTC QLQ-OV28, FACIT-O, NFOSI-18 and QOL-OVCA. All were developed and validated for use in clinical trials, but none had been validated for use in clinical quality registry. Our expert steering committee pre-determined purpose of a PROM tool for use within the NGOR was to enable cross-service comparison and benchmarking to drive quality improvements. They identified that while there was no ideal, pre-existing, ovarian cancer-specific PROM tool for implementation into the NGOR, on the basis of its psychometric properties, its available translations, its length and its ability to be adapted, the EORTC tool is most fit-for-purpose for integration into the NGOR.This process enabled identification of the tool most appropriate to provide insights into how ovarian cancer treatments impact patients' quality of life and permit benchmarking across health services.
- Publisher
- BioMed Central
- Keywords
- Humans; Female; *Ovarian Neoplasms/therapy; *Patient Reported Outcome Measures; *Registries; *Quality of Life; Australia; Clinical quality registry; Gynaecological cancer; Ovarian cancer; Patient reported outcome measures; Quality of life
- Department(s)
- Health Services Research
- Publisher's Version
- https://doi.org/10.1186/s12913-024-11042-8
- Open Access at Publisher's Site
https://doi.org/10.1186/s12913-024-11042-8- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-08-06 05:29:20
Last Modified: 2024-08-06 05:31:19